Search results for "Obstetrics and Gynecology"

showing 10 items of 1542 documents

To invade, or to observe, that is the question

2018

0301 basic medicinePloidies030219 obstetrics & reproductive medicinebusiness.industryCell CycleEmbryonic DevelopmentObstetrics and GynecologyBiologyCell cycleTime-Lapse ImagingCell biologyKinetics03 medical and health sciences030104 developmental biology0302 clinical medicineText miningReproductive MedicinebusinessFertility and Sterility
researchProduct

Evidence that the endometrial microbiota has an effect on implantation success or failure

2016

Background Bacterial cells in the human body account for 1–3% of total body weight and are at least equal in number to human cells. Recent research has focused on understanding how the different bacterial communities in the body (eg, gut, respiratory, skin, and vaginal microbiomes) predispose to health and disease. The microbiota of the reproductive tract has been inferred from the vaginal bacterial communities, and the uterus has been classically considered a sterile cavity. However, while the vaginal microbiota has been investigated in depth, there is a paucity of consistent data regarding the existence of an endometrial microbiota and its possible impact in reproductive function. Objecti…

0301 basic medicinePregnancy RatePrevotellaUterusPhysiologyPilot ProjectsEndometriumPolymerase Chain ReactionEndometrium0302 clinical medicinePregnancyRNA Ribosomal 16SLactobacillusProspective Studiesmedia_commonPrincipal Component Analysis030219 obstetrics & reproductive medicineMicrobiotaObstetrics and GynecologyGeneral MedicineGardnerella vaginalisBacterial Typing TechniquesTreatment Outcomemedicine.anatomical_structureVaginaVaginaFemaleLive birthLive Birthmedicine.medical_specialtymedia_common.quotation_subjectFertilization in VitroBiology03 medical and health sciencesmedicineHumansEmbryo ImplantationMicrobiomeMenstrual CycleMenstrual cycleGynecologyPregnancySequence Analysis RNAbusiness.industryLuteinizing HormoneEmbryo Transfermedicine.diseasebiology.organism_classificationLactobacillusLogistic Models030104 developmental biologySpainCase-Control StudiesInfertilityMultivariate AnalysisbusinessGenome BacterialAmerican Journal of Obstetrics and Gynecology
researchProduct

Introduction

2019

Timely and appropriate medical care can significantly influence the health of a newborn. When considering how to best deliver such care, we must first note that each human represents the result of a balance between nature (genetics) and nurture (environment). Importantly, while most of our care is centered on in utero development, the preconception period is also a time at which genetic and environmental factors can interact to exert effects that ultimately influence the health of the future offspring. In this issue's Views and Reviews, we provide data to suggest that modern preconceptional care should become a key component of reproductive medicine, not only to improve implantation and pre…

0301 basic medicinePregnancymedicine.medical_specialtyWindow of opportunity030219 obstetrics & reproductive medicinebusiness.industrymedia_common.quotation_subjectReproductive medicineObstetrics and Gynecologymedicine.diseaseNature versus nurtureChild healthPerinatal morbidity03 medical and health sciencesAdult life030104 developmental biology0302 clinical medicinePromotion (rank)Reproductive MedicineNursingMedicinebusinessmedia_commonFertility and Sterility
researchProduct

Innovations in assisted reproductive technologies: impact on contemporary donor egg practice and future advances.

2018

Innovations in assisted reproductive technologies (ART) have driven progress in the donor egg field since the birth of the first baby derived from a donor egg in 1983. Over time, donor oocytes have become an increasingly used option for patients unable to conceive with autologous oocytes. In donor egg, the unique separation of the oocyte source and recipient uterus has created a model that has propelled advances in ART. Progressive ART innovations that have optimized the oocyte donor and resulting embryo include the following: evaluation of ovarian reserve, controlled ovarian hyperstimulation regimens that reduce the risk of ovarian hyperstimulation syndrome, blastocyst culture, oocyte cryo…

0301 basic medicineReproductive Techniques Assistedmedicine.medical_treatmentOvarian hyperstimulation syndromeReproductive technologyControlled ovarian hyperstimulationAndrologyEmbryo Culture Techniques03 medical and health sciences0302 clinical medicineInventionsMedicineHumansBlastocystOvarian reserveOvarian Reserve030219 obstetrics & reproductive medicineAssisted reproductive technologyOocyte Donationbusiness.industryObstetrics and GynecologyOocyte cryopreservationmedicine.diseaseOocyte030104 developmental biologymedicine.anatomical_structureReproductive MedicineFemalebusinessForecastingFertility and sterility
researchProduct

Long-term vitamin D treatment decreases human uterine leiomyoma size in a xenograft animal model

2019

Objective To study the effects of short- and long-term vitamin D treatment on uterine leiomyomas in vivo through cell proliferation, extracellular matrix (ECM) degradation, and apoptosis. Design Preclinical study of human leiomyoma treatment with vitamin D in an nonhuman animal model. Setting Hospital and university laboratories. Patient(s)/Animal(s) Human leiomyomas were collected from patients and implanted in ovariectomized NOD-SCID mice. Intervention(s) Mice were treated with vitamin D (0.5 μg/kg/d or 1 μg/kg/d) or vehicle for 21 or 60 days. Main Outcome Measure(s) Vitamin D effect in xenograft tissue was assessed by monitoring tumor size (18F-FDG positron-emission tomography/computeriz…

0301 basic medicineVitaminmedicine.medical_specialtyMice SCIDDrug Administration ScheduleMice03 medical and health scienceschemistry.chemical_compound0302 clinical medicineMice Inbred NODPositron Emission Tomography Computed TomographyInternal medicinemedicineVitamin D and neurologyAnimalsHumansVitamin DCell Proliferation030219 obstetrics & reproductive medicineUterine leiomyomaLeiomyomabusiness.industryObstetrics and Gynecologymedicine.diseaseXenograft Model Antitumor AssaysTumor BurdenBlotTreatment Outcome030104 developmental biologyLeiomyomaEndocrinologyReproductive MedicinechemistryApoptosisPlasminogen activator inhibitor-1Ovariectomized ratFemalebusinessFertility and Sterility
researchProduct

The most well kept secret, embryo culture media: a smart reveal from an expert.

2017

0301 basic medicineWorld Wide WebEmbryo Culture Techniques03 medical and health sciences030219 obstetrics & reproductive medicine030104 developmental biology0302 clinical medicineReproductive MedicineComputer scienceObstetrics and GynecologyEmbryo cultureEmbryo TransferCulture MediaFertility and sterility
researchProduct

The use of morphokinetic as a predictor of implantation.

2017

In recent years the increased efforts intended for improving future outcomes in the laboratory have focused mostly on the search of additional markers of embryo quality to add up present embryo selection criteria. Time-lapse system involves an alternative tool in assisted reproduction techniques, being able to improve the embryo selection from a dynamic and interactive approach while standard embryo assessment implies a subjective and static morphology evaluation and consequently reducing the information gained for embryo selection, time-lapse technology adds several morphokinetic parameters, providing additional input for embryo evaluation. This further information represents a challenge f…

0301 basic medicineanimal structures030219 obstetrics & reproductive medicinePregnancy RateReproductive Techniques Assistedbusiness.industryObstetrics and GynecologyEmbryoTime-Lapse Imaging03 medical and health sciencesKinetics030104 developmental biology0302 clinical medicineRisk analysis (engineering)Pregnancyembryonic structuresMedicineHumansFemaleEmbryo ImplantationbusinessSelection (genetic algorithm)Embryo qualityMinerva ginecologica
researchProduct

Micro-RNA profile and proteins in peritoneal fluid from women with endometriosis: their relationship with sterility.

2018

Objective: To define the microRNA (miRNA) profile and its relationship with cytokines content in peritoneal fluid (PF) from endometriosis patients. Design: Case-control study. Setting: University hospital, research institute. Patient(s): One hundred twenty-six women with endometriosis (EPF) and 45 control women (CPF). Main Outcomes Measure(s): MiRNA arrays were prepared from six EPF and six CPF. Quantitative reverse transcription-polymerase chain reaction validation of nine selected miRNAs (miR-29c-3p, -106b-3p, -130a-3p, -150-5p, -185-5p, -195-5p, -451a, -486-5p, and -1343-5p) was performed. Vascular endothelial growth factor-A (VEGF-A), thrombospondin-1 (TSP-1), urokinase plasminogen acti…

0301 basic medicineendometriosisAdultProteomicsMMP3AngiogenesisEndometriosisEndometriosisEnzyme-Linked Immunosorbent AssayAndrology03 medical and health sciences0302 clinical medicinePregnancymedicineAscitic FluidHumansAngiogenic ProteinsMacrophage inflammatory proteinOligonucleotide Array Sequence Analysis030219 obstetrics & reproductive medicinemicroRNAbusiness.industryPeritoneal fluidGene Expression ProfilingObstetrics and GynecologyInterleukinProteinsMiddle Agedmedicine.diseaseFold changeMicroRNAs030104 developmental biologyperitoneal fluidFertilityReproductive MedicineinflammationCase-Control StudiesCytokinesFemaleAngiogenesisInflammation MediatorsbusinessTranscriptomePlasminogen activatorInfertility FemaleFertility and sterility
researchProduct

Introduction

2020

Randomized-controlled trials (RCTs) and meta-analyses are the pinnacle of evidence-based medicine, enabling identification of the best available diagnostic, interventional, and therapeutic options. These tools help clinicians and policy-makers to set clinical guidelines, but they also represent a double-edged sword: the meaningfulness of RCTs and meta-analyses relies on their quality, performance, and integrity. The present Views and Reviews collection prepared by 18 renowned experts and coordinated by Ben Mol aims to inform and educate our readers about RCTs and meta-analyses in reproductive medicine. The collection begins with the basic features that guarantee the quality of a trial, incl…

0301 basic medicinemedicine.medical_specialty030219 obstetrics & reproductive medicineFuture studiesmedia_common.quotation_subjectReproductive medicineObstetrics and Gynecologylaw.inventionUnmet needs03 medical and health sciencesIdentification (information)030104 developmental biology0302 clinical medicineReproductive MedicineRandomized controlled trialRisk analysis (engineering)lawMeta-analysismedicineQuality (business)PsychologySet (psychology)media_commonFertility and Sterility
researchProduct

Indications and practice of diverting ileostomy after colorectal resection and anastomosis in ovarian cancer cytoreduction.

2020

Objective. To determine the factors related with diverting ileostomy performance after colorectal resection and anastomosis, in advanced ovarian cancer cytoreductive surgery. Methods. We have previously demonstrated the risk factors associated with anastomotic leak after colorectal anastomosis: Advanced age at surgery, low serum albumin level, additional bowel resections, manual anastomosis and distance of the anastomosis from the anal verge. However, use of diverting ileostomy is strongly variable and depends on individual surgeon preferences and training. Eight hospitals participated in this retrospective study. Data of 695 patients operated for ovarian cancer with primary colorectal anas…

0301 basic medicinemedicine.medical_specialtyBevacizumabAnastomotic LeakGynecologic oncologyAnastomosisStomaCohort Studies03 medical and health sciences0302 clinical medicineDiverting ileostomyOvarian cancerAnastomotic leakMedicineHumansPractice Patterns Physicians'AgedNeoplasm StagingRetrospective StudiesOvarian Neoplasmsbusiness.industryIleostomyAnastomosis SurgicalObstetrics and GynecologyRetrospective cohort studyPerioperativeCytoreduction Surgical Proceduresmedicine.diseaseNeoadjuvant TherapySurgeryBevacizumab030104 developmental biologyRisk factorsOncology030220 oncology & carcinogenesisCohortFemaleRisk factorbusinessOvarian cancerColorectal Neoplasmsmedicine.drugGynecologic oncology
researchProduct